Home › Lung Diseases › Texas › Lewisville
Lung Diseases clinical trials in Lewisville, TX
3 studies for Lung Diseases are looking for participants at sites in and around Lewisville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
RecruitingPhase 3
- Epic Clinical Research, Lewisville
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
RecruitingPhase 2
- Prime Clinical Research - Lewisville, Lewisville
A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
RecruitingPhase 2
- Research Site, Lewisville
About Lung Diseases
Lung diseases are disorders or infections that affect the lungs and cause breathing problems. Some can lead to respiratory failure. Find out more about prevention, living with lung diseases, and treatment.
More about Lung Diseases on MedlinePlus
Lung Diseases trials in other cities
- Houston, TX15 studies
- Boston, MA14 studies
- Durham, NC13 studies
- New York City, NY12 studies
- Pittsburgh, PA11 studies
- Los Angeles, CA10 studies
- Columbus, OH10 studies
- Dallas, TX10 studies
- Nashville, TN10 studies
- Washington, DC10 studies
- Miami, FL10 studies
- Ann Arbor, MI10 studies
Other studies in Lewisville
- Ulcerative Colitis10 studies
- Crohn's Disease9 studies
- Breast Cancer5 studies
- Type 2 Diabetes5 studies
- Digestive Diseases4 studies
- Spinal Muscular Atrophy4 studies
- Inflammatory Bowel Disease4 studies
- Colorectal Cancer3 studies
- Steatotic Liver Disease3 studies
- Triple-Negative Breast Cancer3 studies
- Metastatic Cancer3 studies
- Cardiovascular Disease3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.